PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Pharmacierge raises GBP1.25m to streamline prescription medicine process for clinicians and patients

Pharmacierge, a health-tech company that offers same-day prescription medicine delivery in London and next day delivery throughout the UK, today announces that it has raised GBP1.25 million from a number of leading clinicians and angel investors.

Investors include Alex Chesterman OBE, founder of Cazoo and Zoopla and Simon Franks, who co-founded Lovefilm. In a show of confidence from the medical profession, many practitioner users have also invested in the round, including two past presidents of the Independent Doctors Federation, and clinicians practicing variously at the Schoen Clinic, One Welbeck, Hormone Health, Physicians Clinic, Cromwell, Wellington, Lister and King Edward VII Hospitals.

With the money raised, Pharmacierge will now look to expand its footprint throughout the UK and internationally, as well as growing its network of clinicians.

The problem is well known within the medical industry. Private medical practices currently spend up to two hours a day on prescription-related admin tasks, totalling more than 50 working days per year across their practice. The Pharmacierge e-prescription app, mPrescribe, can cut admin by up to 15 minutes per prescription with integrated same day or next day delivery. This saves time for clinicians, their administrative staff and ultimately their patients.

mPrescribe – Pharmacierge’s iPhone and Android enabled app, is the first of its kind in the UK; a portable e-prescription pad that allows clinicians to prescribe medication on the go.  Its seamless infrastructure is built on proprietary full-stack technology, combining Electronic Prescription (EPS) and dispensary management (ERP) systems, with multiple APIs to handle the compliance and complexity of this tightly regulated industry.

In developing the platform, Pharmacierge brought together a multidisciplinary team and advisors with decades of clinical, pharmacy, healthcare and technical expertise – including from Google, Babylon Health, HCA and The Doctors Laboratory. The team pooled years of data and user experience in pharmacy fulfilment, designing an app from the ground up – creating their own software that positions them for scale, international expansion and licensing opportunities.

This software leadership has in turn attracted prominent tech investors including Alex Chesterman OBE, Founder of online car retailer, Cazoo, who says: “Consumers increasingly expect services to be accessible digitally and delivered to their door rapidly, and the pharmacy market is clearly next.”

Pharmacierge co-founder and CEO Edward Ungar says: “Pharmacierge has grown rapidly in the last few years but to have our users, including many of the UK’s leading independent clinicians, support us through investment is a great testament to our dispensary and tech teams and the value we bring to practices and patients. We’ve delivered to a departure lounge and backstage before a rock concert. It all starts with the philosophy of saying yes, we can try to do that.”

Pharmacierge co-founder Robert Ungar says: “The healthcare industry faces a number of challenges, not least due to the widespread disruption from Covid-19. Cumbersome and paper-based processes need to be replaced by streamlined apps that are quick and easy, both for the clinician and the patient. A fast and reliable delivery service for prescription medication is therefore a requirement for private clinicians who put patient-centred care at the heart of their practice.”

Pharmacierge operates its own dispensary and supplies all common medicines. Due to the variety of Consultants it supports, its formulary contains more than double the range of medicines listed by an average NHS trust. The technology solves all the clinical management problems: combining seamless dispensing with courier delivery, and updating doctors and patients as to their prescriptions’ progress.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured